期刊文献+

宫颈癌常规放疗后输尿管狭窄的危险因素分析 被引量:4

Analysis of risk factors associated with ureteral stricture in patients with cervical cancer after radiotherapy
下载PDF
导出
摘要 目的探讨宫颈癌患者放疗后致输尿管狭窄的相关危险因素。方法回顾性分析332例接受常规放疗后宫颈癌患者发生输尿管狭窄的情况,并对年龄、诱导化疗、同时期化疗、辅助化疗、临床分期、病理类型、分化程度、是否近距离治疗、近距离治疗剂量、盆腔外照射剂量、总剂量、是否手术以及是否合并糖尿病或高血压等因素进行分析,筛选与输尿管狭窄有关的危险因素。进一步采用Logistic回归进行独立危险因素的分析,并用Kaplan-Meier法分析了临床分期和双"J"管置入后输尿管狭窄患者的中位时间。结果 332例患者有33例(9.9%)出现输尿管狭窄;664侧输尿管有40侧(6.02%)出现狭窄。Logistic回归分析证实手术和总剂量是宫颈癌放疗后输尿管狭窄发生的独立危险因素。输尿管狭窄发生后双"J"管置入和Ⅰ/Ⅱ期肿瘤的预后明显好于未行双"J"管置入和Ⅲ/Ⅳ期肿瘤,P均<0.05。结论手术和总剂量是宫颈癌患者放疗后发生输尿管狭窄的独立危险因素。 Objective To investigate the risk factors associated with ureteral stricture(US)in patients after radiotherapy. Methods Retrospectively analyzed the clinical characteristics of 332 patients with cervical cancer,including age,induction chemotherapy,concurrent chemotherapy,adjuvant chemotherapy,clinical stage,pathology,differentiation,brachytherapy(BT),BT dose,external beam radiation therapy dose(EBRT),total dose,surgery,diabetes or hypertension. Multivariate Logistic regression analysis was performed to analyze the independent risk factors of US. Kaplan-Meier analysis was used to analyze the overall survival rate. Results Totally 33 in 332 patients developed US(9.9%),and 40 in 664 ureteral developed US(6.02%). Multivariate analysis confirmed that surgery and total dose were independent risk factors of US. Kaplan-Meier analysis showed that patients with Ⅰ/Ⅱ stage and double-J-catheter had significant high overall survival rate. Conclusion Surgery and total dose were independent risk factors of US in patients with cervical cancer after radiotherapy.
作者 陈婷 杨瑾 余孝丽 白守民 CHEN Ting YANG Jin YU Xiaoli BAI Shoumin(Department of Oncological Radiotherapy, Sun Yat-sen Memorial hospital of Sun Yat-sen University, Guangzhou 510120, China.)
出处 《岭南现代临床外科》 2017年第1期50-54,共5页 Lingnan Modern Clinics in Surgery
基金 广东省科技计划项目(2013B021800095)
关键词 宫颈癌 常规放疗 输尿管狭窄 危险因素 cervical cancer radiotherapy ureteral stricture risk factors
  • 相关文献

参考文献1

二级参考文献8

  • 1Havrilesky L J, Leath CA, Huh W. Radical hysterectomy and pelvic lyphadenectomy for stage Ib2 cervical cancer. Gynecol Oncol, 2004 ; 93(2) :429-434.
  • 2Eifel PJ. Chemoradlotherapy in the treatment of cervical cancer. Semin Radiat Oncol, 2006 ; 16(3) : 177-185.
  • 3Fujikawa K, Miyamoto T, lhara Y, et al. High incidence of serve urologic complications following radiotherapy for cervical cancer in Japanese women. Gynecol Oncol, 2001 ; 80(1) : 21-23.
  • 4Gellrich J, Hakenberg OW, Oehlschlager S, et al. Manifestation, latency and management of late urological complications after curative radiotherapy for cervical carcinoma. Onkologie, 2003 ; 26(4) : 334-340.
  • 5Weiss JP, Mattei DM, Neville EC, et al. Primary treatment of radiation-induced hemorrhagic cystitis with hyperbaric oxygen: 10-year experience. J Urol, 1994 ; 151(6) : 1514-1517.
  • 6Blanco DA, Fernandez RE, Alvarez CL, et al. Double-barreled wet colostomy: analysis of a urinary diversion. Actas Urol Esp, 2003 ; 27(8) : 611-617.
  • 7Tabakov ID, Slavchev BN. Large post-hysterectomy and postradiation vesicovagimal fistulas: repair by ileocystoplasty. J Urol,2004;171(1) :272-274.
  • 8Ahamad A, D’ Souza W, Salehpour M, et al. Intensity- modulated radiation therapy after hysterectomy : comparison with conventional treatment and sensitivity of the normal-tlssuesparing effect to margin size. Int J Radiat Oncol Biol Phys, 2005 ; 62(4) : 1117-1124.

共引文献4

同被引文献26

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部